SCHEMBL28964800

SCHEMBL28964800

CCOC(=O)C1(Cc2ccccc2)CCN(Cc2ccccc2)CC1O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.52
GAA P10253 3/20 0.51
LMNA P02545 3/20 0.51
KDM4E B2RXH2 2/20 0.51
KMT2A Q03164 6/20 0.50
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPK1 P28482 1/20 0.49
POLB P06746 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
MAPT P10636 1/20 0.48
HTT P42858 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23534223 0.90 CYP3A4 (0.48) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL15437816 0.88 LMNA (0.51) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL348867 0.87 KDM4E (0.53) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL349998 0.87 KDM4E (0.53) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL28964761 0.87 L3MBTL1 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL18896634 0.84 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL15592014 0.84 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL18896637 0.84 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL15592013 0.84 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL4807305 0.78 KDM4E (0.51) GAALMNAKDM4EKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115734966-A Heterocyclic compounds and their use 石药集团中奇制药技术(石家庄)有限公司 2023-03-03 CN disclosed